{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-038016","form_type":"8-K","ticker":"PRME","cik":"0001894562","company_name":"Prime Medicine, Inc.","filed_at":"2024-02-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.260683+00:00","generated_at":"2026-06-06T00:25:55.937748+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Prime Medicine prices $150.9M public offering of common stock and pre-funded warrants","bullets":["Offering of 19,200,001 shares at $6.25/share plus pre-funded warrants for 3,200,005 shares.","Net proceeds estimated at approximately $150.9M after underwriting discounts and expenses.","Proceeds to fund R&D, clinical development, and general corporate purposes.","Closing expected on or about February 20, 2024, subject to customary conditions.","Underwriters granted 30-day option to purchase up to an additional 3,360,000 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-038016","json":"https://secwatch.observer/filing/0001193125-24-038016.json","markdown":"https://secwatch.observer/filing/0001193125-24-038016.md","text":"https://secwatch.observer/filing/0001193125-24-038016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894562/000119312524038016/0001193125-24-038016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894562/000119312524038016/d721402d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T00:25:55.937748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}